Serum neopterin and ischemia modified albumin levels are associated with the disease activity of adult immunoglobulin A vasculitis (Henoch‐Schönlein purpura). (14th August 2019)
- Record Type:
- Journal Article
- Title:
- Serum neopterin and ischemia modified albumin levels are associated with the disease activity of adult immunoglobulin A vasculitis (Henoch‐Schönlein purpura). (14th August 2019)
- Main Title:
- Serum neopterin and ischemia modified albumin levels are associated with the disease activity of adult immunoglobulin A vasculitis (Henoch‐Schönlein purpura)
- Authors:
- Omma, Ahmet
Colak, Seda
Can Sandikci, Sevinc
Yucel, Cigdem
Erden, Abdulsamet
Sertoglu, Erdim
Ozgurtas, Taner - Abstract:
- Abstract: Aim: The aims of the study are to investigate serum neopterin and ischemia modified albumin (IMA) levels in patients with immunoglobulin A vasculitis (IgAV) and evaluate the association of these markers with disease activity and relapse. Method: Thirty‐four consecutive adult patients (24 male and 10 female) admitted to the rheumatology clinic and met the IgAV American College of Rheumatology (ACR) criteria were enrolled in this cross‐sectional study. Demographic and clinical features of IgAV and a control group were recorded into a predefined protocol. Disease activity was categorized as "remission" or "active" according to Birmingham Vasculitis Activity Score (BVAS). BVAS ≥ 1 was accepted as "active". Serum neopterin levels, high‐sensitivity C‐reactive protein (hsCRP) and IMA were evaluated according to BVAS and compared to the healthy control group. Results: Serum median (interquartile range) neopterin, IMA levels and hsCRP were higher in the study group than in control group (2.01 [12.5] ng/mL vs 1.77 [1.37] ng/mL, 0.67 [0.2] ng/mL vs. 0.43 [0.17] ng/mL, 5.6 [17.1] mg/L vs. 1.55 [1.6] mg/L, P = .095, P < .001 and P = .002, respectively). When evaluated according to BVAS, IMA and hsCRP levels were significantly higher in the group with active disease (0.77 [0.12] vs 0.61 [0.13] and 14.85 [4.6], P = .009 and P = .03, respectively). Serum neopterin levels were significantly higher in the active group compared to BVAS (18.95 [32.36] vs 1.63 [1.48], P < .001).Abstract: Aim: The aims of the study are to investigate serum neopterin and ischemia modified albumin (IMA) levels in patients with immunoglobulin A vasculitis (IgAV) and evaluate the association of these markers with disease activity and relapse. Method: Thirty‐four consecutive adult patients (24 male and 10 female) admitted to the rheumatology clinic and met the IgAV American College of Rheumatology (ACR) criteria were enrolled in this cross‐sectional study. Demographic and clinical features of IgAV and a control group were recorded into a predefined protocol. Disease activity was categorized as "remission" or "active" according to Birmingham Vasculitis Activity Score (BVAS). BVAS ≥ 1 was accepted as "active". Serum neopterin levels, high‐sensitivity C‐reactive protein (hsCRP) and IMA were evaluated according to BVAS and compared to the healthy control group. Results: Serum median (interquartile range) neopterin, IMA levels and hsCRP were higher in the study group than in control group (2.01 [12.5] ng/mL vs 1.77 [1.37] ng/mL, 0.67 [0.2] ng/mL vs. 0.43 [0.17] ng/mL, 5.6 [17.1] mg/L vs. 1.55 [1.6] mg/L, P = .095, P < .001 and P = .002, respectively). When evaluated according to BVAS, IMA and hsCRP levels were significantly higher in the group with active disease (0.77 [0.12] vs 0.61 [0.13] and 14.85 [4.6], P = .009 and P = .03, respectively). Serum neopterin levels were significantly higher in the active group compared to BVAS (18.95 [32.36] vs 1.63 [1.48], P < .001). Conclusion: Oxidative stress is important in IgAV pathogenesis. Roles of hsCRP, neopterin and IMA as potential markers of diagnosis and disease activity seem to be worth studying in future studies with larger study groups. … (more)
- Is Part Of:
- International journal of rheumatic diseases. Volume 22:Number 10(2019)
- Journal:
- International journal of rheumatic diseases
- Issue:
- Volume 22:Number 10(2019)
- Issue Display:
- Volume 22, Issue 10 (2019)
- Year:
- 2019
- Volume:
- 22
- Issue:
- 10
- Issue Sort Value:
- 2019-0022-0010-0000
- Page Start:
- 1920
- Page End:
- 1925
- Publication Date:
- 2019-08-14
- Subjects:
- disease activity -- IgA vasculitis -- ischemia modified albumin -- neopterin -- relapse
Rheumatology -- Periodicals
Rheumatology -- Asia -- Periodicals
Rheumatology -- Pacific Area -- Periodicals
Rheumatic Diseases -- Periodicals
Connective Tissue Diseases -- Periodicals
Immune System Diseases -- Periodicals
616.723 - Journal URLs:
- http://ejournals.ebsco.com/direct.asp?JournalID=715072 ↗
http://www.blackwell-synergy.com/loi/ijrd ↗
http://www.blackwellpublishing.com/aims.asp?ref=1756-1841&site=1 ↗
http://www3.interscience.wiley.com/journal/120118343/grouphome/home.html ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1756-185X ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/1756-185X.13673 ↗
- Languages:
- English
- ISSNs:
- 1756-1841
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.538180
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12052.xml